A review and specialist survey found limited evidence for replacing clobazam during shortages, with variable proposed dose equivalence.
The authors examined alternative benzodiazepines for epilepsy and surveyed specialist practice. Clonazepam and nitrazepam were common proposed substitutes, but suggested equivalence varied, particularly for clonazepam. Many specialists considered switching problematic because seizures and adverse effects could worsen.
This was not a randomized head-to-head substitution trial. Expert preferences and published equivalence suggestions do not establish a precise conversion for an individual. Clobazam’s pharmacology and its epilepsy indication make simple milligram comparisons especially misleading.
In a medication-error or continuity-of-care review, obtain the reason for substitution, overlap and taper history, seizure course, monitoring, and adverse effects. A shortage can create clinical risk even when another drug is available. The paper supports supervised individualized decisions rather than an automatic exchange ratio.
Source reviewed: Which are the options and dosages for clobazam shortages on epilepsy treatment Review of literature (PMC12417036). This article summarizes the supplied paper; forensic applications above are interpretive analysis.
Related reading: UK–Norway Rescue-Medication Survey Found Different Training and Review Practices; A Synthetic Cannabinoid Enhanced Clonazepam but Not Clobazam in One Mouse Seizure Model.